InvestorsHub Logo
Followers 0
Posts 1200
Boards Moderated 0
Alias Born 05/05/2017

Re: None

Thursday, 10/18/2018 8:26:08 AM

Thursday, October 18, 2018 8:26:08 AM

Post# of 44784
Have Yaky & Zami put the most important EAP venture in the company's history into the hands of a 10-month-old clinical trial start-up? Sure looks that way.

Leadership there seems to have passion, but no history of execution with what will be a MISSION CRITICAL safety and efficacy trial for approval of PLX-PAD.

The 2012 debacle over the 'compassionate use' EAP, has left investors leary and short of trust for psti's leadership. Remember the company's announcement by Zami, over the seemingly 'cured' patients, who later passed away?!?!?!

https://www.benzinga.com/news/12/05/2572600/from-earlier-compassionate-use-of-pluristems-plx-cells-saves-the-life-of-a-child-

One would think we might want to select a Tried, True, Proven trial leader to conduct this CRITICAL trial. As zzaat, fda, etal. have stated, these trials are 'high risk' for psti...

IMAGINE... just imagine if 'something' goes wrong with psti being the FIRST customer... IMHO